Literature DB >> 2902901

Effects of intrahypothalamic administration of opioid peptides selective for mu-, kappa, and delta-receptors on different schedules of water intake in the rat.

M Ukai1, S G Holtzman.   

Abstract

The effects of opioid peptides selective for mu, kappa, and delta-opioid receptors were investigated on 3 different schedules of water intake in the rat: spontaneous, deprivational (12 h), and hypertonic saline-induced drinking. Peptides were injected into the paraventricular and supraoptic hypothalamic nuclei, D-Ala2-NMePhe4-Gly(ol)-enkephalin, a mu-selective opioid agonist, tended to increase water intake in non-deprived rats, but 0.01 and 0.1 microgram significantly decreased water intake for 45 min in deprived rats, and for up to 60 min in hypertonic saline-injected rats when injected into the paraventricular hypothalamic nucleus. The kappa-selective agonist, dynorphin A1-13 (0.1, 0.3, 1.0 and 3.0 micrograms)and the delta-selective agonist, [D-Pen2,L-Pen5]enkephalin (0.3 and 3.0 micrograms) did not affect spontaneous, deprivational or hypertonic saline-induced water intakes when injected into either the paraventricular or supraoptic hypothalamic nuclei. Thus, a mu-selective opioid peptide produced dose- and time-dependent effects on drinking that were pharmacologically and anatomically specific, and dependent upon the schedule of water intake.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902901     DOI: 10.1016/0006-8993(88)90643-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Pharmacological treatments for psychosis-related polydipsia.

Authors:  G Brookes; A G Ahmed
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

2.  The kappa-opioid U-50,488H suppresses the initiation of nocturnal spontaneous drinking in normally hydrated rats.

Authors:  A Badiani; J Stewart
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats.

Authors:  Carsten K Nielsen; Jeffrey A Simms; Haley B Pierson; Rui Li; Surendra K Saini; Subramaniam Ananthan; Selena E Bartlett
Journal:  Biol Psychiatry       Date:  2008-09-06       Impact factor: 13.382

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.